• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算机断层扫描显示甲状腺功能异常性视神经病变的视神经乳头顶端受压

Apical optic nerve compression of dysthyroid optic neuropathy on computed tomography.

作者信息

Kennerdell J S, Rosenbaum A E, El-Hoshy M H

出版信息

Arch Ophthalmol. 1981 May;99(5):807-9. doi: 10.1001/archopht.1981.03930010807002.

DOI:10.1001/archopht.1981.03930010807002
PMID:6894536
Abstract

Computed assisted tomography (CT) of seven cases of dysthyroid optic neuropathy showed moderate to severe thickening of the extraocular muscles at the orbital apex, white CT of two control cases of dysthyroid orbitopathy without neuropathy showed minimal or fusiform thickening. The consequences include probable apical compression with optic nerve neuropathy either by direct pressure on the nerve or its blood supply. The management of these cases is either by oral administration of corticosteroids in high dosage with gradual tapering or radiation therapy to the orbital apex (approximately 3,000 rad over a ten-day period). If surgical decompression is to be attempted, it should be designed to decompress the optic nerve at the orbital apex.

摘要

计算机辅助断层扫描(CT)显示,7例甲状腺功能异常性视神经病变患者眶尖处眼外肌呈中度至重度增厚,2例无神经病变的甲状腺功能异常性眼眶病对照病例的CT图像显示眼外肌仅有轻微增厚或呈梭形增厚。其后果可能是眶尖对视神经的压迫,无论是直接压迫神经还是其血供。这些病例的治疗方法要么是口服高剂量皮质类固醇并逐渐减量,要么是对眶尖进行放射治疗(10天内约3000拉德)。如果要尝试手术减压,应设计为对眶尖处的视神经进行减压。

相似文献

1
Apical optic nerve compression of dysthyroid optic neuropathy on computed tomography.计算机断层扫描显示甲状腺功能异常性视神经病变的视神经乳头顶端受压
Arch Ophthalmol. 1981 May;99(5):807-9. doi: 10.1001/archopht.1981.03930010807002.
2
CT scan evidence of dysthyroid optic neuropathy.甲状腺功能异常性视神经病变的CT扫描证据。
Ophthalmic Plast Reconstr Surg. 2002 May;18(3):177-82. doi: 10.1097/00002341-200205000-00005.
3
Graves orbitopathy: correlation of CT and clinical findings.格雷夫斯眼眶病:CT与临床检查结果的相关性
Radiology. 1990 Dec;177(3):675-82. doi: 10.1148/radiology.177.3.2243967.
4
Visual field and orbital computed tomography correlation in dysthyroid optic neuropathy due to thyroid eye disease.甲状腺眼病所致甲状腺功能亢进性视神经病变的视野与眼眶 CT 相关性。
Orbit. 2020 Apr;39(2):77-83. doi: 10.1080/01676830.2019.1600150. Epub 2019 May 6.
5
Color Doppler imaging of orbital venous flow in dysthyroid optic neuropathy.甲状腺功能异常性视神经病变眼眶静脉血流的彩色多普勒成像
Jpn J Ophthalmol. 1994;38(1):80-6.
6
Reversal of dysthyroid optic neuropathy following orbital fat decompression.眼眶脂肪减压术后甲状腺相关眼病性视神经病变的逆转
Br J Ophthalmol. 2000 Jun;84(6):600-5. doi: 10.1136/bjo.84.6.600.
7
Optic nerve dysfunction in thyroid eye disease: CT.甲状腺眼病中的视神经功能障碍:CT
Radiology. 1988 May;167(2):503-7. doi: 10.1148/radiology.167.2.3357962.
8
Clinical and radiological characteristics of Graves' orbitopathy patients showing spontaneous decompression.表现为自发性减压的格雷夫斯眼眶病患者的临床和影像学特征
J Craniomaxillofac Surg. 2015 Jan;43(1):48-52. doi: 10.1016/j.jcms.2014.10.008. Epub 2014 Oct 22.
9
Predicting dysthyroid optic neuropathy using computed tomography volumetric analyses of orbital structures.基于眼眶结构 CT 容积分析预测甲状腺相关眼病性视神经病变。
Clinics (Sao Paulo). 2012 Aug;67(8):891-6. doi: 10.6061/clinics/2012(08)06.
10
Optic nerve involvement in Graves' ophthalmopathy: a case report and review.
Aust N Z J Med. 1985 Apr;15(2):258-61. doi: 10.1111/j.1445-5994.1985.tb04021.x.

引用本文的文献

1
Teprotumumab's Impact on Proptosis in Long-duration Thyroid Eye Disease: A Systematic Review and Meta-analysis.替普罗单抗对长期甲状腺眼病眼球突出的影响:一项系统评价和荟萃分析。
touchREV Endocrinol. 2024 Oct;20(2):100-109. doi: 10.17925/EE.2024.20.2.13. Epub 2024 Oct 15.
2
Dysthyroid Optic Neuropathy Dramatically Improved by Sheath-Guided Triamcinolone Orbital Injection: A Case Report.鞘内注射曲安奈德治疗甲状腺功能异常性视神经病变效果显著:一例报告
Cureus. 2024 Sep 29;16(9):e70437. doi: 10.7759/cureus.70437. eCollection 2024 Sep.
3
Changes in retinal nerve fiber layer, ganglion cell complex, and ganglion cell layer thickness in thyroid eye disease: A systematic review.
甲状腺眼病患者视网膜神经纤维层、神经节细胞复合体及神经节细胞层厚度的变化:一项系统评价
Taiwan J Ophthalmol. 2023 Feb 20;14(2):217-224. doi: 10.4103/tjo.TJO-D-22-00110. eCollection 2024 Apr-Jun.
4
Assessment of retinal and choroidal vessel density and nerve fibre layer thickness changes after orbitotomy in patients with severe non-active thyroid orbitopathy: a prospective study.重度非活动性甲状腺眼病患者眼眶手术后视网膜和脉络膜血管密度及神经纤维层厚度变化的评估:一项前瞻性研究。
Int Ophthalmol. 2023 Dec;43(12):4427-4433. doi: 10.1007/s10792-023-02790-3. Epub 2023 Oct 25.
5
Macular retinal and choroidal thickness profile in patients with thyroid-associated orbitopathy compared to healthy individuals: A cross-sectional study.与健康个体相比,甲状腺相关性眼病患者的黄斑视网膜和脉络膜厚度分布:一项横断面研究。
Health Sci Rep. 2023 Oct 3;6(10):e1604. doi: 10.1002/hsr2.1604. eCollection 2023 Oct.
6
Optical coherence tomography and electrophysiological analysis of proptotic eyes due to thyroid-associated ophthalmopathy.甲状腺相关眼病所致眼球突出患者的光学相干断层扫描和电生理分析。
Int Ophthalmol. 2023 Jun;43(6):2057-2064. doi: 10.1007/s10792-022-02605-x. Epub 2022 Dec 8.
7
Optic nerve head optical coherence tomography angiography findings in patients with thyroid eye disease: a case-control study.甲状腺眼病患者的视神经乳头光学相干断层扫描血管造影结果:一项病例对照研究。
Thyroid Res. 2022 Sep 21;15(1):17. doi: 10.1186/s13044-022-00134-4.
8
Dysthyroid Optic Neuropathy: Treatment with Additional Intravenous Methylprednisolone Pulses after the Basic Schedule Is Associated with Stabilization or Further Improvement of Clinical Outcome.甲状腺功能异常性视神经病变:基础治疗方案后追加静脉注射甲泼尼龙冲击治疗与临床结局稳定或进一步改善相关。
J Clin Med. 2022 Apr 7;11(8):2068. doi: 10.3390/jcm11082068.
9
Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study.替普罗单抗治疗甲状腺功能异常性视神经病变的早期疗效:一项多中心研究。
Am J Ophthalmol Case Rep. 2021 May 14;23:101111. doi: 10.1016/j.ajoc.2021.101111. eCollection 2021 Sep.
10
CT definition of the surgical apex in the orbit.眶部手术顶点的 CT 定义。
Sci Rep. 2021 May 26;11(1):11016. doi: 10.1038/s41598-021-90419-9.